Showing results (31-40 of 85) with videos related to
Sort By:
Pageof 9
Circulation|August 2, 2001
Physiological transport forces govern drug distribution for stent-based deliveryC W Hwang, D Wu, E R EdelmanMedical & Biological Engineering & Computing|March 21, 2000
Measuring arterial strain induced by endovascular stentsJ C Squire, C Rogers, E R EdelmanCirculation|February 4, 1997
Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickeningM G Sirois, M Simons, E R EdelmanCirculation|September 1, 1993
Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administrationC Rogers, M J Karnovsky, E R EdelmanProceedings of the National Academy of Sciences of the United States of America|August 26, 1998
A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbitsC Rogers, E R Edelman, D I SimonProceedings of the National Academy of Sciences of the United States of America|August 29, 1995
Tissue engineered perivascular endothelial cell implants regulate vascular injuryA Nathan, M A Nugent, E R EdelmanBiomaterials|September 1, 1991
Controlled and modulated release of basic fibroblast growth factorE R Edelman, E Mathiowitz, R Langer, et al.Proceedings of the National Academy of Sciences of the United States of America|February 15, 1993
Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ depositionE R Edelman, M A Nugent, M J KarnovskyCirculation|December 19, 2001
Oral heparin prevents neointimal hyperplasia after arterial injury: inhibitory potential depends on type of vascular injuryF G Welt, T C Woods, E R EdelmanCirculation Research|December 1, 1993
Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cellsM A Nugent, M J Karnovsky, E R EdelmanPageof 9